SureTrader Nadex Advertisement PGUS
Home > Boards > US Listed > Biotechs >

Can-Fite BioPharma (CANF)

CANF RSS Feed
Add CANF Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board: 
Last Post: 3/15/2017 8:01:15 PM - Followers: 43 - Board type: Free - Posts Today: 0

Can-Fite BioPharma (TASE: CFBI, OTC: CANFY) is an Israeli biopharmaceutical company with fully integrated pharmaceutical
discovery and clinical development capabilities.
The company has an advanced pipeline of proprietary compounds in phase 2 and 3 clinical development stage, which address
autoimmune-inflammatory and cancer diseases.

Can-Fite has a number of drugs in various stages of research and development. The pipeline drugs are synthetic, highly specific
agonists and an allosteric modulator, all target the A3 adenosine receptor. All drugs are orally bioavailable with an excellent safety profile.
CF101, Can-Fite's lead compound, is an oral drug that has been successfully tested in animal models and is currently in advanced stages
of clinical development for Rheumatoid Arthritis (RA) and Psoriasis. All human clinical studies have demonstrated this drug to have an
excellent safety profile. Phase IIa study data in RA indicates that CF101 has disease modifying anti-inflammatory activity in RA patients
failing methotrexate therapy. The Phase II clinical study in Psoriasis was successfully concluded showing efficacy of CF101, thereby
establishing the basis for further clinical development.

Israeli Office

10 Bareket Street
Kiryat Matalon
P.O. Box 7537
Petah-Tikva 49170
ISRAEL

Tel: +972-3-9241114
Fax: +972-3-9249378

General email:
[email protected]
Press Inquiries

Gelbart Kahana Investor Relations
Tel: +972-3-6074717

USA Office

1000 Winter St., Suite 2000
Waltham
MA 02451
USA
Tel: +972-3-9241114
Fax: +972-3-9249378


General email: [email protected]


http://www.canfite.com/
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CANF
Current Price
Volume:
Bid Ask Day's Range
SureTrader
CANF News: Report of Foreign Issuer (6-k) 02/28/2017 07:13:24 AM
CANF News: New Preclinical Data Show Can-Fite's Namodenoson (CF102) Prevents Progression of Liver Fibrosis 02/28/2017 07:00:00 AM
CANF News: Amended Statement of Ownership (sc 13g/a) 02/10/2017 09:59:44 AM
CANF News: Report of Foreign Issuer (6-k) 02/08/2017 07:13:48 AM
CANF News: Can-Fite Gears Up for ACRobat, its Phase III Trial of Piclidenoson in Rheumatoid Arthritis 02/08/2017 07:00:00 AM
PostSubject
#1105   Keeps going down ... yikes Pan Am 03/15/17 08:01:15 PM
#1104   Preclinical is a very midastouch017 03/01/17 02:38:52 AM
#1103   Was hoping for an up tick ... this Pan Am 02/28/17 06:04:44 PM
#1102   crazy how this is only up by a [SMART MONEY] 02/28/17 09:59:24 AM
#1101   CANF: Ready to Start Two Phase III Trials midastouch017 02/23/17 01:46:05 PM
#1100   surprised not more volume,, looks good. blulotus 02/08/17 04:33:48 PM
#1099   Can-Fite Gears Up for ACRobat, its Phase III midastouch017 02/08/17 07:26:52 AM
#1098   Maybe another Pharm getting in at a deep discount? Pan Am 01/19/17 12:17:02 PM
#1097   Well, it keeps them floating! midastouch017 01/19/17 11:14:38 AM
#1096   So is this good or bad... long run? Pan Am 01/19/17 11:05:36 AM
#1095   The reason for the drop: midastouch017 01/19/17 08:10:59 AM
#1094   Yep. Just wouldn't have surprised me... alwaysontop 01/18/17 04:38:52 PM
#1093   Nowhere near green. Anythinggi 01/18/17 04:24:39 PM
#1092   It may not, but wouldn't surprise me at alwaysontop 01/18/17 03:33:33 PM
#1091   It refers to a particular type of stock alwaysontop 01/18/17 03:16:07 PM
#1090   With all that buying, and the midastouch017 01/18/17 03:07:41 PM
#1089   That, or someone buying a ton of em alwaysontop 01/18/17 03:01:16 PM
#1088   Highly irregular indeed! midastouch017 01/18/17 01:23:54 PM
#1087   Why all the volume today? Thoughts?? alwaysontop 01/18/17 11:03:32 AM
#1086   Celgene's Otezla Will Survive Against Can-Fite's Piclidenoson midastouch017 01/17/17 12:39:35 PM
#1085   Can-Fite Receives IRB Approval to Commence Patient Enrollment midastouch017 01/09/17 08:33:01 AM
#1084   Can-Fite Receives $500,000 Payment as Part of $3 midastouch017 12/21/16 08:08:04 AM
#1083   Can-Fite Reports Financial Results for Nine Months Ended midastouch017 11/25/16 08:49:09 AM
#1082   Can-Fite Receives Notice of Allowance From U.S. Patent midastouch017 11/09/16 07:46:05 AM
#1081   Can-Fite to Participate in BIO-Europe Partnering Conference on midastouch017 11/07/16 08:05:19 AM
#1080   Can-Fite Signs Distribution Deal for Liver Cancer Drug midastouch017 10/25/16 08:14:04 AM
#1079   Can-Fite Submits Protocol for Phase II Trial of midastouch017 10/13/16 08:13:06 AM
#1078   NASH event today to inform investors midastouch017 10/05/16 11:47:59 AM
#1077   BTW, i do not particularly like midastouch017 09/29/16 11:37:38 AM
#1076   All true—it was the Dirks 1973 case that DewDiligence 09/29/16 11:37:21 AM
#1075   About Ray Dirks (from the article): midastouch017 09/29/16 11:26:14 AM
#1074   Inasmuch as your CANF post is from Ray DewDiligence 09/29/16 11:16:32 AM
#1073   Allergan's $1.7 Billion Acquisition of Tobira for NASH midastouch017 09/29/16 09:12:22 AM
#1072   CF102 currently preparing Phase II trial in NASH zino 09/25/16 04:20:55 PM
#1071   CANF Website, http://ir.canfite.com/ zino 09/22/16 11:57:37 PM
#1070   CANF PRESENTATION zino 09/22/16 11:47:57 PM
#1069   Allergan buys another NASH therapy developer for zino 09/22/16 11:22:14 PM
#1068   Someone painted it, but huge closing over 200 alwaysontop 09/21/16 04:51:01 PM
#1067   market cap under 40 million wont last here zino 09/20/16 09:59:12 AM
#1066   "We have a growing body of data pointing zino 09/20/16 09:57:34 AM
#1065   CF102 is in phase 2 trials !!!! zino 09/20/16 09:55:46 AM
#1064   Phase II study of NAFLD/NASH is completed and zino 09/20/16 09:52:38 AM
#1063   after tbra buy out zino 09/20/16 09:49:30 AM
#1062   MARKET REPRICING YHESE LIVER BIO- PLAYS... zino 09/20/16 09:49:05 AM
#1061   "We have a growing body of data pointing crudeoil24 09/20/16 09:07:40 AM
#1060   Can-Fite Reports New Data on CF102's Liver Protective midastouch017 09/20/16 08:50:56 AM
#1059   Rodman and Renshaw give it a buy! XJINVESTOR 08/30/16 10:36:02 AM
#1058   Can-Fite Reports Financial Results for Six Months Ended midastouch017 08/26/16 08:12:40 AM
#1057   Can-Fite Reports New Data Showing its Psoriasis Drug midastouch017 06/15/16 09:24:54 AM
#1056   Can-Fite to Exhibit at Bio International Convention in midastouch017 06/04/16 07:58:42 AM
PostSubject